The biotech companies you should keep an eye out for in 2024
Welcome to the 55 new subscribers who joined our LinkedIn newsletter last week ?? If not done yet, subscribe to join the 5,033 fans of the Pick of the Week!
As 2023 comes to a close, the biotechnology industry is brimming with potential, with many companies currently spearheading scientific innovation.
And in 2024, it's likely that we will continue to see the same.
In fact, a diverse range of companies are poised to break new ground when it comes to tackling global challenges.
This week we take a look at nine exciting biotech companies we think you should look out for in 2024.
To find out more, read the full article: "Nine biotech companies to watch in 2024 "
领英推荐
?? More noteworthy articles from this week:
Although there is currently no cure for glioblastoma, CAR-T cell therapy has shown success in preclinical and early clinical studies and could be the best hope for successfully treating - and perhaps even curing - this aggressive form of brain cancer.
Precision medicine - which tailors treatments based on people’s genetic makeup, lifestyle, and environment - can tackle a range of diseases, and there are now many biopharma companies focused on this type of approach, hoping to get their clinical candidates to market.
After a difficult few years, there is now hope that 2024 will bring the funds for vital clinical research and cutting-edge technology that could redefine care for diseases and conditions that have limited or non-existent treatment options.
??Enjoying these articles??Never miss a single publication of Labiotech by becoming a part of our community! Click here to join our mailing list.